

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Golgi transport vesicle coating (GO:0048200) | 9.09054317 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 9.09054317 |
| 3 | intestinal cholesterol absorption (GO:0030299) | 7.89074886 |
| 4 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 7.63551169 |
| 5 | positive regulation of respiratory burst (GO:0060267) | 7.40766026 |
| 6 | positive regulation of nuclease activity (GO:0032075) | 7.36543611 |
| 7 | regulation of nuclease activity (GO:0032069) | 6.88770873 |
| 8 | digestion (GO:0007586) | 6.70699337 |
| 9 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 6.66775082 |
| 10 | * ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 6.50918727 |
| 11 | * endoplasmic reticulum unfolded protein response (GO:0030968) | 6.34535674 |
| 12 | * response to endoplasmic reticulum stress (GO:0034976) | 6.29472196 |
| 13 | proline biosynthetic process (GO:0006561) | 6.27095533 |
| 14 | COPII vesicle coating (GO:0048208) | 6.22302169 |
| 15 | * cellular response to unfolded protein (GO:0034620) | 6.18742627 |
| 16 | negative regulation of glucose import (GO:0046325) | 5.95361697 |
| 17 | * cellular response to topologically incorrect protein (GO:0035967) | 5.94772731 |
| 18 | complement activation, classical pathway (GO:0006958) | 5.86370449 |
| 19 | * ER-nucleus signaling pathway (GO:0006984) | 5.75650588 |
| 20 | intestinal epithelial cell development (GO:0060576) | 5.75500909 |
| 21 | regulation of respiratory burst (GO:0060263) | 5.46753406 |
| 22 | * protein N-linked glycosylation via asparagine (GO:0018279) | 5.44280153 |
| 23 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 5.43706666 |
| 24 | * peptidyl-asparagine modification (GO:0018196) | 5.40566842 |
| 25 | GDP-mannose metabolic process (GO:0019673) | 5.38690734 |
| 26 | cell redox homeostasis (GO:0045454) | 5.26346523 |
| 27 | protein maturation by protein folding (GO:0022417) | 5.19706737 |
| 28 | * response to unfolded protein (GO:0006986) | 5.08852371 |
| 29 | * protein N-linked glycosylation (GO:0006487) | 4.97491360 |
| 30 | glomerular filtration (GO:0003094) | 4.96060730 |
| 31 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 4.94002075 |
| 32 | * response to topologically incorrect protein (GO:0035966) | 4.91901127 |
| 33 | ER overload response (GO:0006983) | 4.83938259 |
| 34 | transcytosis (GO:0045056) | 4.71223559 |
| 35 | apoptotic cell clearance (GO:0043277) | 4.66671020 |
| 36 | positive regulation of growth hormone secretion (GO:0060124) | 4.61928460 |
| 37 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.58897487 |
| 38 | immunoglobulin mediated immune response (GO:0016064) | 4.57573690 |
| 39 | valine metabolic process (GO:0006573) | 4.57408761 |
| 40 | mitochondrial calcium ion transport (GO:0006851) | 4.53129798 |
| 41 | negative regulation of glucose transport (GO:0010829) | 4.46360854 |
| 42 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 4.46022807 |
| 43 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.44251921 |
| 44 | complement activation (GO:0006956) | 4.41425497 |
| 45 | maintenance of protein localization in organelle (GO:0072595) | 4.39399519 |
| 46 | proline metabolic process (GO:0006560) | 4.33195489 |
| 47 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.31698049 |
| 48 | zinc ion transport (GO:0006829) | 4.31292010 |
| 49 | renal filtration (GO:0097205) | 4.27080103 |
| 50 | sequestering of metal ion (GO:0051238) | 4.25417583 |
| 51 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.21949919 |
| 52 | regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768) | 4.21506999 |
| 53 | antibacterial humoral response (GO:0019731) | 4.17156928 |
| 54 | branched-chain amino acid catabolic process (GO:0009083) | 4.16802001 |
| 55 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.15562207 |
| 56 | positive regulation of antigen processing and presentation (GO:0002579) | 4.15051322 |
| 57 | regulation of antigen processing and presentation (GO:0002577) | 4.13389480 |
| 58 | regulation of phospholipase A2 activity (GO:0032429) | 4.10884825 |
| 59 | humoral immune response (GO:0006959) | 4.10287582 |
| 60 | antimicrobial humoral response (GO:0019730) | 4.08284133 |
| 61 | protein activation cascade (GO:0072376) | 4.07234465 |
| 62 | 4-hydroxyproline metabolic process (GO:0019471) | 3.99873030 |
| 63 | detection of bacterium (GO:0016045) | 3.99580822 |
| 64 | peptidyl-proline hydroxylation (GO:0019511) | 3.99429628 |
| 65 | intestinal absorption (GO:0050892) | 3.94842751 |
| 66 | vesicle coating (GO:0006901) | 3.88548492 |
| 67 | cysteine metabolic process (GO:0006534) | 3.86924607 |
| 68 | mature B cell differentiation involved in immune response (GO:0002313) | 3.80370048 |
| 69 | branched-chain amino acid metabolic process (GO:0009081) | 3.78719473 |
| 70 | cellular response to antibiotic (GO:0071236) | 3.74952772 |
| 71 | detection of other organism (GO:0098543) | 3.72249495 |
| 72 | cobalamin metabolic process (GO:0009235) | 3.69987252 |
| 73 | glycolipid catabolic process (GO:0019377) | 3.69077892 |
| 74 | regulation of cellular extravasation (GO:0002691) | 3.69001580 |
| 75 | epithelial cell maturation (GO:0002070) | 3.68758594 |
| 76 | positive regulation of B cell differentiation (GO:0045579) | 3.63330994 |
| 77 | B cell mediated immunity (GO:0019724) | 3.61643087 |
| 78 | L-fucose catabolic process (GO:0042355) | 3.60478188 |
| 79 | fucose catabolic process (GO:0019317) | 3.60478188 |
| 80 | L-fucose metabolic process (GO:0042354) | 3.60478188 |
| 81 | muscle organ morphogenesis (GO:0048644) | 3.60337783 |
| 82 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 3.57211419 |
| 83 | Fc-gamma receptor signaling pathway (GO:0038094) | 3.57211419 |
| 84 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 3.57211419 |
| 85 | B cell receptor signaling pathway (GO:0050853) | 3.56719285 |
| 86 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 3.55132823 |
| 87 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.49521639 |
| 88 | response to type I interferon (GO:0034340) | 3.45255932 |
| 89 | membrane lipid catabolic process (GO:0046466) | 3.43301957 |
| 90 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.43296533 |
| 91 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.42778469 |
| 92 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.42778469 |
| 93 | cellular response to type I interferon (GO:0071357) | 3.42761574 |
| 94 | type I interferon signaling pathway (GO:0060337) | 3.42761574 |
| 95 | defense response to protozoan (GO:0042832) | 3.42640868 |
| 96 | ER to Golgi vesicle-mediated transport (GO:0006888) | 3.39916517 |
| 97 | sterol catabolic process (GO:0016127) | 3.39856989 |
| 98 | cholesterol catabolic process (GO:0006707) | 3.39856989 |
| 99 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.39278402 |
| 100 | galactose catabolic process (GO:0019388) | 3.35090531 |
| 101 | nucleotide-sugar metabolic process (GO:0009225) | 3.34005884 |
| 102 | cellular response to ATP (GO:0071318) | 3.31740247 |
| 103 | nucleoside diphosphate catabolic process (GO:0009134) | 3.31427804 |
| 104 | negative regulation of digestive system process (GO:0060457) | 3.30206733 |
| 105 | cellular modified amino acid catabolic process (GO:0042219) | 3.28137150 |
| 106 | Peyers patch development (GO:0048541) | 3.28081977 |
| 107 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.28081977 |
| 108 | serine family amino acid biosynthetic process (GO:0009070) | 3.24968197 |
| 109 | NIK/NF-kappaB signaling (GO:0038061) | 3.24880190 |
| 110 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.21443595 |
| 111 | regulation of growth hormone secretion (GO:0060123) | 3.14404525 |
| 112 | regulation of gamma-delta T cell activation (GO:0046643) | 3.13390006 |
| 113 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.12413021 |
| 114 | chaperone-mediated protein folding (GO:0061077) | 3.10845811 |
| 115 | Golgi organization (GO:0007030) | 3.10602497 |
| 116 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.08654915 |
| 117 | fucose metabolic process (GO:0006004) | 3.08476625 |
| 118 | negative regulation of cell killing (GO:0031342) | 3.08364552 |
| 119 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.08364552 |
| 120 | protein hydroxylation (GO:0018126) | 3.08147225 |
| 121 | monoamine transport (GO:0015844) | 3.07465015 |
| 122 | protein targeting to ER (GO:0045047) | 3.07096821 |
| 123 | maternal placenta development (GO:0001893) | 3.07006627 |
| 124 | mannose metabolic process (GO:0006013) | 3.06480811 |
| 125 | positive thymic T cell selection (GO:0045059) | 3.06115033 |
| 126 | L-serine metabolic process (GO:0006563) | 3.05934514 |
| 127 | cotranslational protein targeting to membrane (GO:0006613) | 3.03963886 |
| 128 | tolerance induction (GO:0002507) | 3.02330471 |
| 129 | mature B cell differentiation (GO:0002335) | 3.02108619 |
| 130 | germinal center formation (GO:0002467) | 3.00595988 |
| 131 | response to interferon-beta (GO:0035456) | 2.99327806 |
| 132 | response to protozoan (GO:0001562) | 2.97427570 |
| 133 | protein folding (GO:0006457) | 2.95121236 |
| 134 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.94927570 |
| 135 | protein localization to endoplasmic reticulum (GO:0070972) | 2.92591846 |
| 136 | ceramide catabolic process (GO:0046514) | 2.92422729 |
| 137 | respiratory burst (GO:0045730) | 2.89843108 |
| 138 | endocrine pancreas development (GO:0031018) | 2.88787246 |
| 139 | regulation of B cell differentiation (GO:0045577) | 2.87849986 |
| 140 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.87225439 |
| 141 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.87175650 |
| 142 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.86342283 |
| 143 | negative regulation of glycogen biosynthetic process (GO:0045719) | 2.84470758 |
| 144 | cellular response to interferon-gamma (GO:0071346) | 2.84262776 |
| 145 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.83631414 |
| 146 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.82363463 |
| 147 | retina homeostasis (GO:0001895) | 2.79207207 |
| 148 | glutamine metabolic process (GO:0006541) | 2.77892490 |
| 149 | cellular response to interferon-beta (GO:0035458) | 2.77286985 |
| 150 | negative regulation of B cell apoptotic process (GO:0002903) | 2.74503049 |
| 151 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.72979631 |
| 152 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.72456862 |
| 153 | myeloid dendritic cell activation (GO:0001773) | 2.70908204 |
| 154 | response to interferon-gamma (GO:0034341) | 2.67624834 |
| 155 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.66915357 |
| 156 | angiotensin maturation (GO:0002003) | 2.66622152 |
| 157 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.64764623 |
| 158 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.63048407 |
| 159 | T cell costimulation (GO:0031295) | 2.62840361 |
| 160 | dendritic cell chemotaxis (GO:0002407) | 2.62260115 |
| 161 | negative regulation of phagocytosis (GO:0050765) | 2.61877771 |
| 162 | regulation of guanylate cyclase activity (GO:0031282) | 2.61754861 |
| 163 | lymphocyte costimulation (GO:0031294) | 2.59333692 |
| 164 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.59098065 |
| 165 | production of molecular mediator of immune response (GO:0002440) | 2.56865515 |
| 166 | cellular response to virus (GO:0098586) | 2.54611934 |
| 167 | detection of external biotic stimulus (GO:0098581) | 2.52952984 |
| 168 | DNA strand elongation (GO:0022616) | 2.52330372 |
| 169 | thymic T cell selection (GO:0045061) | 2.51208718 |
| 170 | pyrimidine nucleoside salvage (GO:0043097) | 2.49588940 |
| 171 | pyrimidine-containing compound salvage (GO:0008655) | 2.49588940 |
| 172 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.47635550 |
| 173 | deoxyribonucleotide catabolic process (GO:0009264) | 2.45467350 |
| 174 | B cell homeostasis (GO:0001782) | 2.42237345 |
| 175 | positive regulation of neutrophil migration (GO:1902624) | 2.42179050 |
| 176 | positive regulation of neutrophil chemotaxis (GO:0090023) | 2.42179050 |
| 177 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.42009648 |
| 178 | regulation of necrotic cell death (GO:0010939) | 2.41224980 |
| 179 | positive regulation by symbiont of host defense response (GO:0052509) | 2.41176939 |
| 180 | modulation by symbiont of host defense response (GO:0052031) | 2.41176939 |
| 181 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.41176939 |
| 182 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.41176939 |
| 183 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.41176939 |
| 184 | modulation by symbiont of host immune response (GO:0052553) | 2.41176939 |
| 185 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.40922950 |
| 186 | negative regulation of innate immune response (GO:0045824) | 2.40265036 |
| 187 | positive regulation of pseudopodium assembly (GO:0031274) | 2.38867790 |
| 188 | exocrine pancreas development (GO:0031017) | 12.8004526 |
| 189 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 11.0730993 |
| 190 | protein retention in ER lumen (GO:0006621) | 10.5842538 |
| 191 | signal peptide processing (GO:0006465) | 10.3776820 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.59286749 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.63108790 |
| 3 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.90978021 |
| 4 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.59510093 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.46755935 |
| 6 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.36062447 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.33015868 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.69672582 |
| 9 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.55436983 |
| 10 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.46513974 |
| 11 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.38136676 |
| 12 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.35698027 |
| 13 | MYC_22102868_ChIP-Seq_BL_Human | 2.34843025 |
| 14 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.32909714 |
| 15 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.29054157 |
| 16 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.28697577 |
| 17 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.27668264 |
| 18 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.27668264 |
| 19 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.27668264 |
| 20 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.12534168 |
| 21 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.11785832 |
| 22 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.11526095 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.08561427 |
| 24 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.08240599 |
| 25 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.05443047 |
| 26 | MAF_26560356_Chip-Seq_TH1_Human | 2.05288284 |
| 27 | UTX_26944678_Chip-Seq_JUKART_Human | 2.02791263 |
| 28 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.02369733 |
| 29 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.93838479 |
| 30 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.87189988 |
| 31 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.84467019 |
| 32 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.83934423 |
| 33 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.83496965 |
| 34 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.81419158 |
| 35 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.80137958 |
| 36 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.77082631 |
| 37 | MAF_26560356_Chip-Seq_TH2_Human | 1.76997116 |
| 38 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.76112868 |
| 39 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.71571157 |
| 40 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.71503483 |
| 41 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71386229 |
| 42 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.68519587 |
| 43 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.66666820 |
| 44 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.63947985 |
| 45 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.63650732 |
| 46 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.63475125 |
| 47 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.63096544 |
| 48 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.62927368 |
| 49 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.62793475 |
| 50 | * P68_20966046_ChIP-Seq_HELA_Human | 1.62102514 |
| 51 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.61148895 |
| 52 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.59305036 |
| 53 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.58302220 |
| 54 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.57469803 |
| 55 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.57050222 |
| 56 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.56443878 |
| 57 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.55650499 |
| 58 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.51671859 |
| 59 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.51458804 |
| 60 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.46080461 |
| 61 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.45816317 |
| 62 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.44910097 |
| 63 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.44821309 |
| 64 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.44283974 |
| 65 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.41407052 |
| 66 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.41207844 |
| 67 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.41167001 |
| 68 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.40757238 |
| 69 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.38361397 |
| 70 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.36931782 |
| 71 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.35895910 |
| 72 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.35792219 |
| 73 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.35148357 |
| 74 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.34325328 |
| 75 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.34296947 |
| 76 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.33679467 |
| 77 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.33096689 |
| 78 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.32489635 |
| 79 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.32435170 |
| 80 | * CHD1_26751641_Chip-Seq_LNCaP_Human | 1.32289207 |
| 81 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.31253186 |
| 82 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.30700955 |
| 83 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.30043605 |
| 84 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.29680179 |
| 85 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.29407182 |
| 86 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.27723212 |
| 87 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26471958 |
| 88 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.26385087 |
| 89 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.26137780 |
| 90 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25486935 |
| 91 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.25328374 |
| 92 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.25209301 |
| 93 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.24580711 |
| 94 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23961095 |
| 95 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23328198 |
| 96 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.23024771 |
| 97 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.23006433 |
| 98 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.22534573 |
| 99 | P300_27268052_Chip-Seq_Bcells_Human | 1.22459149 |
| 100 | SA1_27219007_Chip-Seq_Bcells_Human | 1.22434056 |
| 101 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.22368420 |
| 102 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.21047187 |
| 103 | * TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.20580674 |
| 104 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.20477948 |
| 105 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.20294298 |
| 106 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.20048466 |
| 107 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.19717299 |
| 108 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.19713070 |
| 109 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.18744984 |
| 110 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.18698580 |
| 111 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.18447036 |
| 112 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.16923751 |
| 113 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.16602642 |
| 114 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.16558081 |
| 115 | * YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.16387608 |
| 116 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15807671 |
| 117 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.15639868 |
| 118 | * CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.15175770 |
| 119 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.15129727 |
| 120 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.13576642 |
| 121 | SPI1_23127762_ChIP-Seq_K562_Human | 1.13216853 |
| 122 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.13214124 |
| 123 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.12459740 |
| 124 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.10066090 |
| 125 | GATA1_19941826_ChIP-Seq_K562_Human | 1.09223491 |
| 126 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09056328 |
| 127 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.08066336 |
| 128 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.07842758 |
| 129 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.06871489 |
| 130 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.05459249 |
| 131 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.05189470 |
| 132 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.04287129 |
| 133 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.04208995 |
| 134 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.03567855 |
| 135 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.02979022 |
| 136 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.02157112 |
| 137 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.01745696 |
| 138 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.01654441 |
| 139 | MYB_26560356_Chip-Seq_TH2_Human | 1.01020895 |
| 140 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.00529516 |
| 141 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99494134 |
| 142 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.99487030 |
| 143 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.99217709 |
| 144 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.98984679 |
| 145 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98647836 |
| 146 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.98286969 |
| 147 | GATA1_22025678_ChIP-Seq_K562_Human | 0.97976619 |
| 148 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.97265320 |
| 149 | MYB_26560356_Chip-Seq_TH1_Human | 0.96866207 |
| 150 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96824414 |
| 151 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.96096581 |
| 152 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.96092477 |
| 153 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.96072945 |
| 154 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.95866583 |
| 155 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.95315419 |
| 156 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.95129976 |
| 157 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.94984960 |
| 158 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.94462291 |
| 159 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.94343443 |
| 160 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.94319866 |
| 161 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.94028219 |
| 162 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.93705634 |
| 163 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.93560054 |
| 164 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.92590201 |
| 165 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.91428921 |
| 166 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.91276801 |
| 167 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.90005526 |
| 168 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.89490891 |
| 169 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.88469868 |
| 170 | GATA3_26560356_Chip-Seq_TH1_Human | 0.88216522 |
| 171 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.87699536 |
| 172 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.87200829 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001666_abnormal_nutrient_absorption | 6.61874082 |
| 2 | MP0005220_abnormal_exocrine_pancreas | 6.10132962 |
| 3 | MP0005083_abnormal_biliary_tract | 5.69981332 |
| 4 | MP0005365_abnormal_bile_salt | 5.08646840 |
| 5 | MP0004264_abnormal_extraembryonic_tissu | 4.77284814 |
| 6 | MP0010234_abnormal_vibrissa_follicle | 3.89624420 |
| 7 | MP0002693_abnormal_pancreas_physiology | 3.50764359 |
| 8 | MP0000685_abnormal_immune_system | 3.19571860 |
| 9 | MP0003868_abnormal_feces_composition | 3.15150534 |
| 10 | MP0003724_increased_susceptibility_to | 2.92699038 |
| 11 | MP0001944_abnormal_pancreas_morphology | 2.86213714 |
| 12 | MP0005025_abnormal_response_to | 2.72006123 |
| 13 | MP0002139_abnormal_hepatobiliary_system | 2.54157379 |
| 14 | MP0005084_abnormal_gallbladder_morpholo | 2.50533739 |
| 15 | MP0005085_abnormal_gallbladder_physiolo | 2.42915078 |
| 16 | MP0003693_abnormal_embryo_hatching | 2.18816599 |
| 17 | MP0005310_abnormal_salivary_gland | 2.14164027 |
| 18 | MP0002148_abnormal_hypersensitivity_rea | 2.11949016 |
| 19 | MP0002396_abnormal_hematopoietic_system | 2.11297082 |
| 20 | MP0009278_abnormal_bone_marrow | 2.09512548 |
| 21 | MP0009785_altered_susceptibility_to | 2.06308165 |
| 22 | MP0002419_abnormal_innate_immunity | 2.04193170 |
| 23 | MP0000613_abnormal_salivary_gland | 2.03010714 |
| 24 | MP0002398_abnormal_bone_marrow | 2.00052983 |
| 25 | MP0004043_abnormal_pH_regulation | 1.99415628 |
| 26 | MP0003195_calcinosis | 1.96790093 |
| 27 | MP0002138_abnormal_hepatobiliary_system | 1.92010381 |
| 28 | MP0001835_abnormal_antigen_presentation | 1.73628032 |
| 29 | MP0000465_gastrointestinal_hemorrhage | 1.72740037 |
| 30 | MP0001664_abnormal_digestion | 1.67433682 |
| 31 | MP0002429_abnormal_blood_cell | 1.65584822 |
| 32 | MP0002722_abnormal_immune_system | 1.65033881 |
| 33 | MP0005451_abnormal_body_composition | 1.63104748 |
| 34 | MP0009643_abnormal_urine_homeostasis | 1.61897940 |
| 35 | MP0003959_abnormal_lean_body | 1.56797056 |
| 36 | MP0004233_abnormal_muscle_weight | 1.52080982 |
| 37 | MP0005464_abnormal_platelet_physiology | 1.50398232 |
| 38 | MP0010386_abnormal_urinary_bladder | 1.50300321 |
| 39 | MP0005166_decreased_susceptibility_to | 1.50043117 |
| 40 | MP0000003_abnormal_adipose_tissue | 1.48476058 |
| 41 | MP0003183_abnormal_peptide_metabolism | 1.47470992 |
| 42 | MP0005332_abnormal_amino_acid | 1.46316953 |
| 43 | MP0002405_respiratory_system_inflammati | 1.44726110 |
| 44 | MP0004947_skin_inflammation | 1.44371189 |
| 45 | MP0001873_stomach_inflammation | 1.43813040 |
| 46 | MP0005058_abnormal_lysosome_morphology | 1.40221672 |
| 47 | MP0009379_abnormal_foot_pigmentation | 1.38970005 |
| 48 | MP0004858_abnormal_nervous_system | 1.38275631 |
| 49 | MP0003300_gastrointestinal_ulcer | 1.36584189 |
| 50 | MP0002078_abnormal_glucose_homeostasis | 1.35671711 |
| 51 | MP0001533_abnormal_skeleton_physiology | 1.35605132 |
| 52 | MP0004782_abnormal_surfactant_physiolog | 1.31762023 |
| 53 | MP0006082_CNS_inflammation | 1.31127125 |
| 54 | MP0005397_hematopoietic_system_phenotyp | 1.30963738 |
| 55 | MP0001545_abnormal_hematopoietic_system | 1.30963738 |
| 56 | MP0000703_abnormal_thymus_morphology | 1.30626382 |
| 57 | MP0000490_abnormal_crypts_of | 1.29561008 |
| 58 | MP0005647_abnormal_sex_gland | 1.21907647 |
| 59 | MP0000477_abnormal_intestine_morphology | 1.21735541 |
| 60 | MP0003111_abnormal_nucleus_morphology | 1.19294191 |
| 61 | MP0005636_abnormal_mineral_homeostasis | 1.16337443 |
| 62 | MP0006054_spinal_hemorrhage | 1.16263312 |
| 63 | MP0001800_abnormal_humoral_immune | 1.16138512 |
| 64 | MP0001845_abnormal_inflammatory_respons | 1.15081402 |
| 65 | MP0001765_abnormal_ion_homeostasis | 1.14917580 |
| 66 | MP0002166_altered_tumor_susceptibility | 1.14536483 |
| 67 | MP0000858_altered_metastatic_potential | 1.12960446 |
| 68 | MP0003186_abnormal_redox_activity | 1.10779366 |
| 69 | MP0005387_immune_system_phenotype | 1.09504763 |
| 70 | MP0001790_abnormal_immune_system | 1.09504763 |
| 71 | MP0010094_abnormal_chromosome_stability | 1.07555989 |
| 72 | MP0001764_abnormal_homeostasis | 1.07360000 |
| 73 | MP0005671_abnormal_response_to | 1.06908654 |
| 74 | MP0009840_abnormal_foam_cell | 1.04633929 |
| 75 | MP0005408_hypopigmentation | 1.03021675 |
| 76 | MP0002118_abnormal_lipid_homeostasis | 1.02479055 |
| 77 | MP0009765_abnormal_xenobiotic_induced | 1.02122167 |
| 78 | MP0000609_abnormal_liver_physiology | 1.01221778 |
| 79 | MP0003638_abnormal_response/metabolism_ | 0.99620940 |
| 80 | MP0008260_abnormal_autophagy | 0.98310701 |
| 81 | MP0002877_abnormal_melanocyte_morpholog | 0.97488562 |
| 82 | MP0002132_abnormal_respiratory_system | 0.97151881 |
| 83 | MP0009764_decreased_sensitivity_to | 0.97043355 |
| 84 | MP0002933_joint_inflammation | 0.95068998 |
| 85 | MP0010352_gastrointestinal_tract_polyps | 0.92924246 |
| 86 | MP0000470_abnormal_stomach_morphology | 0.92897147 |
| 87 | MP0002277_abnormal_respiratory_mucosa | 0.91876178 |
| 88 | MP0001986_abnormal_taste_sensitivity | 0.90481054 |
| 89 | MP0008004_abnormal_stomach_pH | 0.89798064 |
| 90 | MP0004957_abnormal_blastocyst_morpholog | 0.88149063 |
| 91 | MP0010307_abnormal_tumor_latency | 0.87960610 |
| 92 | MP0001919_abnormal_reproductive_system | 0.87832131 |
| 93 | MP0010155_abnormal_intestine_physiology | 0.85508951 |
| 94 | MP0005319_abnormal_enzyme/_coenzyme | 0.84735098 |
| 95 | MP0000681_abnormal_thyroid_gland | 0.83978771 |
| 96 | MP0000313_abnormal_cell_death | 0.83516505 |
| 97 | MP0003953_abnormal_hormone_level | 0.83344280 |
| 98 | MP0010329_abnormal_lipoprotein_level | 0.82947956 |
| 99 | MP0005448_abnormal_energy_balance | 0.81463918 |
| 100 | MP0002796_impaired_skin_barrier | 0.80881170 |
| 101 | MP0003763_abnormal_thymus_physiology | 0.80760746 |
| 102 | MP0000639_abnormal_adrenal_gland | 0.79939747 |
| 103 | MP0003077_abnormal_cell_cycle | 0.78956335 |
| 104 | MP0003448_altered_tumor_morphology | 0.78456844 |
| 105 | MP0002452_abnormal_antigen_presenting | 0.78086088 |
| 106 | MP0003806_abnormal_nucleotide_metabolis | 0.76578226 |
| 107 | MP0003075_altered_response_to | 0.75725836 |
| 108 | MP0005075_abnormal_melanosome_morpholog | 0.74744918 |
| 109 | MP0003656_abnormal_erythrocyte_physiolo | 0.74736691 |
| 110 | MP0002723_abnormal_immune_serum | 0.74731976 |
| 111 | MP0003795_abnormal_bone_structure | 0.74593951 |
| 112 | MP0002006_tumorigenesis | 0.74279083 |
| 113 | MP0002909_abnormal_adrenal_gland | 0.72926013 |
| 114 | MP0000598_abnormal_liver_morphology | 0.71647125 |
| 115 | MP0004147_increased_porphyrin_level | 0.71597494 |
| 116 | MP0003252_abnormal_bile_duct | 0.71301938 |
| 117 | MP0008057_abnormal_DNA_replication | 0.70154368 |
| 118 | MP0001663_abnormal_digestive_system | 0.69743375 |
| 119 | MP0009333_abnormal_splenocyte_physiolog | 0.68781649 |
| 120 | MP0009763_increased_sensitivity_to | 0.68429026 |
| 121 | MP0001756_abnormal_urination | 0.67144998 |
| 122 | MP0001879_abnormal_lymphatic_vessel | 0.66584088 |
| 123 | MP0002420_abnormal_adaptive_immunity | 0.66269748 |
| 124 | MP0005381_digestive/alimentary_phenotyp | 0.65692463 |
| 125 | MP0003453_abnormal_keratinocyte_physiol | 0.65280067 |
| 126 | MP0001853_heart_inflammation | 0.64016102 |
| 127 | MP0005390_skeleton_phenotype | 0.63871382 |
| 128 | MP0006036_abnormal_mitochondrial_physio | 0.63088892 |
| 129 | MP0002998_abnormal_bone_remodeling | 0.62708290 |
| 130 | MP0000689_abnormal_spleen_morphology | 0.62327455 |
| 131 | MP0005379_endocrine/exocrine_gland_phen | 0.61287239 |
| 132 | MP0005389_reproductive_system_phenotype | 0.61237835 |
| 133 | MP0001819_abnormal_immune_cell | 0.60583477 |
| 134 | MP0005165_increased_susceptibility_to | 0.60496310 |
| 135 | MP0002136_abnormal_kidney_physiology | 0.60204475 |
| 136 | MP0009780_abnormal_chondrocyte_physiolo | 0.59956395 |
| 137 | MP0005360_urolithiasis | 0.59945446 |
| 138 | MP0002653_abnormal_ependyma_morphology | 0.59221429 |
| 139 | MP0003866_abnormal_defecation | 0.58362990 |
| 140 | MP0005535_abnormal_body_temperature | 0.57161783 |
| 141 | MP0000678_abnormal_parathyroid_gland | 0.56329835 |
| 142 | MP0002928_abnormal_bile_duct | 0.55858005 |
| 143 | MP0003436_decreased_susceptibility_to | 0.55664572 |
| 144 | MP0005000_abnormal_immune_tolerance | 0.54892743 |
| 145 | MP0000013_abnormal_adipose_tissue | 0.54854551 |
| 146 | MP0002098_abnormal_vibrissa_morphology | 0.54377866 |
| 147 | MP0005076_abnormal_cell_differentiation | 0.54178760 |
| 148 | MP0009642_abnormal_blood_homeostasis | 0.54032411 |
| 149 | MP0002896_abnormal_bone_mineralization | 0.53073754 |
| 150 | MP0008469_abnormal_protein_level | 0.52903273 |
| 151 | MP0000716_abnormal_immune_system | 0.51883700 |
| 152 | MP0003303_peritoneal_inflammation | 0.50190670 |
| 153 | MP0002019_abnormal_tumor_incidence | 0.50083599 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 5.15679635 |
| 2 | Abnormality of B cell number (HP:0010975) | 5.13653912 |
| 3 | B lymphocytopenia (HP:0010976) | 5.13653912 |
| 4 | Onycholysis (HP:0001806) | 5.01885797 |
| 5 | Abnormality of the intrinsic pathway (HP:0010989) | 4.63241509 |
| 6 | Colitis (HP:0002583) | 4.47505162 |
| 7 | Steatorrhea (HP:0002570) | 4.22400169 |
| 8 | Abnormal protein glycosylation (HP:0012346) | 4.21712589 |
| 9 | Abnormal glycosylation (HP:0012345) | 4.21712589 |
| 10 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 4.21712589 |
| 11 | Abnormal protein N-linked glycosylation (HP:0012347) | 4.21712589 |
| 12 | Eczematoid dermatitis (HP:0000976) | 4.19668630 |
| 13 | Systemic lupus erythematosus (HP:0002725) | 4.16364676 |
| 14 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.04541618 |
| 15 | Malnutrition (HP:0004395) | 4.01153221 |
| 16 | Recurrent sinusitis (HP:0011108) | 4.00688974 |
| 17 | Recurrent bronchitis (HP:0002837) | 3.94259824 |
| 18 | Hypoplasia of the pons (HP:0012110) | 3.90573556 |
| 19 | Increased IgE level (HP:0003212) | 3.84537311 |
| 20 | Autoimmune thrombocytopenia (HP:0001973) | 3.82611820 |
| 21 | Vacuolated lymphocytes (HP:0001922) | 3.77598054 |
| 22 | Panhypogammaglobulinemia (HP:0003139) | 3.73965651 |
| 23 | Fat malabsorption (HP:0002630) | 3.72315029 |
| 24 | Type I transferrin isoform profile (HP:0003642) | 3.71752568 |
| 25 | Gout (HP:0001997) | 3.71325736 |
| 26 | Abnormality of the pons (HP:0007361) | 3.57915106 |
| 27 | Inflammation of the large intestine (HP:0002037) | 3.55398935 |
| 28 | Obstructive lung disease (HP:0006536) | 3.54752572 |
| 29 | Chronic obstructive pulmonary disease (HP:0006510) | 3.54752572 |
| 30 | Gastrointestinal inflammation (HP:0004386) | 3.47173228 |
| 31 | Abnormality of subcutaneous fat tissue (HP:0001001) | 3.44261742 |
| 32 | Abnormality of the nasal mucosa (HP:0000433) | 3.41723689 |
| 33 | Recurrent bacterial skin infections (HP:0005406) | 3.37000939 |
| 34 | Vasculitis (HP:0002633) | 3.34034623 |
| 35 | Mediastinal lymphadenopathy (HP:0100721) | 3.32941693 |
| 36 | Abnormality of macrophages (HP:0004311) | 3.32420800 |
| 37 | Nasal polyposis (HP:0100582) | 3.29858844 |
| 38 | Recurrent abscess formation (HP:0002722) | 3.28171406 |
| 39 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.21074601 |
| 40 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.20305126 |
| 41 | Ketosis (HP:0001946) | 3.20227317 |
| 42 | Decreased subcutaneous fat (HP:0001002) | 3.18000678 |
| 43 | Exocrine pancreatic insufficiency (HP:0001738) | 3.17388607 |
| 44 | Recurrent fungal infections (HP:0002841) | 3.17309573 |
| 45 | Recurrent viral infections (HP:0004429) | 3.14590232 |
| 46 | Ketoacidosis (HP:0001993) | 3.12320773 |
| 47 | Cellulitis (HP:0100658) | 3.11526675 |
| 48 | IgM deficiency (HP:0002850) | 3.09452631 |
| 49 | Dry hair (HP:0011359) | 3.07174501 |
| 50 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.05284680 |
| 51 | Decreased circulating renin level (HP:0003351) | 3.03989172 |
| 52 | Chronic otitis media (HP:0000389) | 3.02998913 |
| 53 | Recurrent lower respiratory tract infections (HP:0002783) | 3.00519162 |
| 54 | Dysostosis multiplex (HP:0000943) | 2.98213725 |
| 55 | Abnormality of the prostate (HP:0008775) | 2.97608109 |
| 56 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.97161168 |
| 57 | Progressive muscle weakness (HP:0003323) | 2.95418775 |
| 58 | Bronchitis (HP:0012387) | 2.95415118 |
| 59 | Reduced antithrombin III activity (HP:0001976) | 2.93487061 |
| 60 | Papilloma (HP:0012740) | 2.93438723 |
| 61 | Verrucae (HP:0200043) | 2.93438723 |
| 62 | Hypoglycemic coma (HP:0001325) | 2.91650422 |
| 63 | Emphysema (HP:0002097) | 2.91011841 |
| 64 | Autoimmune hemolytic anemia (HP:0001890) | 2.90323412 |
| 65 | Hyperactive renin-angiotensin system (HP:0000841) | 2.89439788 |
| 66 | Abnormal pancreas size (HP:0012094) | 2.84936073 |
| 67 | Generalized aminoaciduria (HP:0002909) | 2.84730677 |
| 68 | Prostate neoplasm (HP:0100787) | 2.81826307 |
| 69 | Cerebellar dysplasia (HP:0007033) | 2.80867181 |
| 70 | Villous atrophy (HP:0011473) | 2.79509688 |
| 71 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.79509688 |
| 72 | Lymphopenia (HP:0001888) | 2.78416628 |
| 73 | Abnormality of the common coagulation pathway (HP:0010990) | 2.76665131 |
| 74 | Recurrent cutaneous fungal infections (HP:0011370) | 2.75743953 |
| 75 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.75743953 |
| 76 | Hypoglycemic seizures (HP:0002173) | 2.73558947 |
| 77 | Type I diabetes mellitus (HP:0100651) | 2.73055277 |
| 78 | Premature loss of primary teeth (HP:0006323) | 2.72540291 |
| 79 | Pancreatitis (HP:0001733) | 2.71519868 |
| 80 | Granulocytopenia (HP:0001913) | 2.67493713 |
| 81 | Abnormality of T cell physiology (HP:0011840) | 2.66176045 |
| 82 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.63177490 |
| 83 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.63177490 |
| 84 | Interstitial pulmonary disease (HP:0006530) | 2.59002828 |
| 85 | Recurrent pneumonia (HP:0006532) | 2.58475932 |
| 86 | Abnormality of T cells (HP:0002843) | 2.57581816 |
| 87 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.57182024 |
| 88 | Joint stiffness (HP:0001387) | 2.56260167 |
| 89 | Type II lissencephaly (HP:0007260) | 2.55269158 |
| 90 | Short chin (HP:0000331) | 2.54398705 |
| 91 | Conical tooth (HP:0000698) | 2.54126922 |
| 92 | Recurrent skin infections (HP:0001581) | 2.50394404 |
| 93 | Squamous cell carcinoma (HP:0002860) | 2.43369810 |
| 94 | Hypergammaglobulinemia (HP:0010702) | 2.42392635 |
| 95 | Myositis (HP:0100614) | 2.39754064 |
| 96 | Basal cell carcinoma (HP:0002671) | 2.38984356 |
| 97 | Vascular calcification (HP:0004934) | 2.38408921 |
| 98 | Pustule (HP:0200039) | 2.35310065 |
| 99 | Sepsis (HP:0100806) | 2.33638218 |
| 100 | Chronic bronchitis (HP:0004469) | 2.32598629 |
| 101 | Maternal diabetes (HP:0009800) | 2.32148374 |
| 102 | Abdominal distention (HP:0003270) | 2.31580960 |
| 103 | Increased IgM level (HP:0003496) | 2.30357226 |
| 104 | Encephalitis (HP:0002383) | 2.29608681 |
| 105 | Chronic diarrhea (HP:0002028) | 2.29025648 |
| 106 | Symptomatic seizures (HP:0011145) | 2.28387170 |
| 107 | Gastrointestinal stroma tumor (HP:0100723) | 2.28090421 |
| 108 | Restrictive lung disease (HP:0002091) | 2.24108640 |
| 109 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.22810474 |
| 110 | Gastrointestinal infarctions (HP:0005244) | 2.21439745 |
| 111 | Abnormality of incisor morphology (HP:0011063) | 2.20758841 |
| 112 | Osteomyelitis (HP:0002754) | 2.19903219 |
| 113 | Abnormality of the fingertips (HP:0001211) | 2.18997855 |
| 114 | Mucopolysacchariduria (HP:0008155) | 2.18887894 |
| 115 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.18887894 |
| 116 | Protuberant abdomen (HP:0001538) | 2.18449782 |
| 117 | Late onset (HP:0003584) | 2.17836392 |
| 118 | Dicarboxylic aciduria (HP:0003215) | 2.17433247 |
| 119 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.17433247 |
| 120 | Ridged nail (HP:0001807) | 2.16225212 |
| 121 | Carpal bone hypoplasia (HP:0001498) | 2.15940480 |
| 122 | Abnormality of male internal genitalia (HP:0000022) | 2.15209660 |
| 123 | Hypertensive crisis (HP:0100735) | 2.14661336 |
| 124 | Abnormality of complement system (HP:0005339) | 2.14079258 |
| 125 | Recurrent otitis media (HP:0000403) | 2.13724973 |
| 126 | Glomerulonephritis (HP:0000099) | 2.12162148 |
| 127 | Gingivitis (HP:0000230) | 2.11203771 |
| 128 | Lymphoma (HP:0002665) | 2.10681720 |
| 129 | Cerebral palsy (HP:0100021) | 2.10532650 |
| 130 | Spontaneous hematomas (HP:0007420) | 2.09194649 |
| 131 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.08815381 |
| 132 | Bronchiectasis (HP:0002110) | 2.08367265 |
| 133 | Leukocytosis (HP:0001974) | 2.07949926 |
| 134 | Alkalosis (HP:0001948) | 2.07141911 |
| 135 | Premature skin wrinkling (HP:0100678) | 2.07046486 |
| 136 | Petechiae (HP:0000967) | 2.05537089 |
| 137 | Hemoptysis (HP:0002105) | 2.04324281 |
| 138 | Cardiovascular calcification (HP:0011915) | 2.03653031 |
| 139 | Skin ulcer (HP:0200042) | 2.03569689 |
| 140 | Eosinophilia (HP:0001880) | 2.01765438 |
| 141 | Limb hypertonia (HP:0002509) | 2.01619451 |
| 142 | Meningitis (HP:0001287) | 2.00174281 |
| 143 | Abnormal tarsal ossification (HP:0008369) | 1.99816969 |
| 144 | Fatigue (HP:0012378) | 1.99269449 |
| 145 | Urticaria (HP:0001025) | 1.98908765 |
| 146 | Ileus (HP:0002595) | 1.98254016 |
| 147 | Ragged-red muscle fibers (HP:0003200) | 1.97954271 |
| 148 | Hyperglycinemia (HP:0002154) | 1.97591919 |
| 149 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.96324181 |
| 150 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.96324181 |
| 151 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.96324181 |
| 152 | Polygenic inheritance (HP:0010982) | 1.94197391 |
| 153 | Hyperglycemia (HP:0003074) | 1.93152181 |
| 154 | IgG deficiency (HP:0004315) | 1.92309491 |
| 155 | Erythema (HP:0010783) | 1.91252779 |
| 156 | Severe combined immunodeficiency (HP:0004430) | 1.91233294 |
| 157 | Thrombocytosis (HP:0001894) | 1.89936203 |
| 158 | Pulmonary infiltrates (HP:0002113) | 1.87976886 |
| 159 | Chest pain (HP:0100749) | 1.87368412 |
| 160 | Dehydration (HP:0001944) | 1.87257382 |
| 161 | Abnormality of the peritoneum (HP:0002585) | 1.87124147 |
| 162 | Congenital glaucoma (HP:0001087) | 1.87120429 |
| 163 | Progressive neurologic deterioration (HP:0002344) | 1.86720524 |
| 164 | Combined immunodeficiency (HP:0005387) | 1.86663167 |
| 165 | Chronic sinusitis (HP:0011109) | 1.84841801 |
| 166 | Blepharitis (HP:0000498) | 1.84201612 |
| 167 | IgA deficiency (HP:0002720) | 1.83274141 |
| 168 | Neutropenia (HP:0001875) | 1.82048677 |
| 169 | Skin rash (HP:0000988) | 1.81155034 |
| 170 | Hypohidrosis (HP:0000966) | 1.79617110 |
| 171 | Thoracic kyphosis (HP:0002942) | 1.79154870 |
| 172 | Hypoplasia of the uterus (HP:0000013) | 1.77841017 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 9.17457542 |
| 2 | BCKDK | 7.65050153 |
| 3 | TAOK3 | 3.70078460 |
| 4 | NME2 | 3.50753969 |
| 5 | EIF2AK3 | 3.09827071 |
| 6 | RIPK4 | 2.95537316 |
| 7 | PRPF4B | 2.92231140 |
| 8 | SMG1 | 2.55466284 |
| 9 | IRAK3 | 2.46842986 |
| 10 | INSRR | 2.34467777 |
| 11 | BLK | 2.25874209 |
| 12 | MAPKAPK3 | 2.00091076 |
| 13 | FRK | 1.96771301 |
| 14 | KIT | 1.92105469 |
| 15 | VRK2 | 1.88746819 |
| 16 | AKT3 | 1.81094899 |
| 17 | TNK2 | 1.79453094 |
| 18 | EEF2K | 1.78313328 |
| 19 | MAP2K2 | 1.63879533 |
| 20 | MAP3K11 | 1.55788331 |
| 21 | MAP3K13 | 1.50832719 |
| 22 | SCYL2 | 1.49740606 |
| 23 | PASK | 1.40207222 |
| 24 | MAPK15 | 1.39531293 |
| 25 | TBK1 | 1.38415117 |
| 26 | FLT3 | 1.37243121 |
| 27 | MAP4K1 | 1.33422701 |
| 28 | ARAF | 1.33387921 |
| 29 | TYK2 | 1.33086897 |
| 30 | BRAF | 1.29496824 |
| 31 | KDR | 1.23401668 |
| 32 | PIK3CG | 1.19780248 |
| 33 | CDC7 | 1.19006622 |
| 34 | CDK4 | 1.18127293 |
| 35 | FGFR4 | 1.17708087 |
| 36 | MST1R | 1.16672146 |
| 37 | KSR2 | 1.16613880 |
| 38 | SIK1 | 1.14974217 |
| 39 | MAP3K9 | 1.14353835 |
| 40 | FES | 1.14105995 |
| 41 | CSK | 1.09940754 |
| 42 | RPS6KB2 | 1.07400056 |
| 43 | IRAK4 | 1.04390809 |
| 44 | MAP3K14 | 1.02905535 |
| 45 | MAP3K2 | 1.02257593 |
| 46 | TRIB3 | 0.99652719 |
| 47 | IKBKE | 0.99492650 |
| 48 | HCK | 0.97904677 |
| 49 | LATS1 | 0.97806262 |
| 50 | TXK | 0.93028690 |
| 51 | IRAK2 | 0.90781843 |
| 52 | HIPK2 | 0.90093851 |
| 53 | PRKD3 | 0.87262290 |
| 54 | TESK2 | 0.86248326 |
| 55 | CDK19 | 0.86199178 |
| 56 | CSF1R | 0.83807198 |
| 57 | MATK | 0.83667084 |
| 58 | STK24 | 0.80278579 |
| 59 | ITK | 0.79392598 |
| 60 | ZAP70 | 0.79389222 |
| 61 | EIF2AK1 | 0.77570272 |
| 62 | PRKCI | 0.71242865 |
| 63 | LCK | 0.69018693 |
| 64 | JAK3 | 0.67926082 |
| 65 | TLK1 | 0.67742902 |
| 66 | TESK1 | 0.67270083 |
| 67 | PIM1 | 0.66975151 |
| 68 | PKN2 | 0.65902882 |
| 69 | MAP2K6 | 0.64126413 |
| 70 | TAOK1 | 0.64070735 |
| 71 | MST4 | 0.62500221 |
| 72 | IRAK1 | 0.62081043 |
| 73 | RAF1 | 0.61710354 |
| 74 | ACVR1B | 0.60210623 |
| 75 | PIM2 | 0.59297364 |
| 76 | TAOK2 | 0.57123893 |
| 77 | CDK12 | 0.56971101 |
| 78 | SYK | 0.54935918 |
| 79 | CDK7 | 0.53818620 |
| 80 | RIPK1 | 0.53504019 |
| 81 | BMX | 0.53123558 |
| 82 | WNK4 | 0.52779741 |
| 83 | MAP3K8 | 0.51484642 |
| 84 | PAK2 | 0.50059957 |
| 85 | CDK9 | 0.49668269 |
| 86 | NME1 | 0.49536902 |
| 87 | PDK1 | 0.47601717 |
| 88 | MAPKAPK2 | 0.46790152 |
| 89 | PRKG2 | 0.45515345 |
| 90 | ATR | 0.44578322 |
| 91 | NTRK1 | 0.44360948 |
| 92 | MAPK12 | 0.43262217 |
| 93 | MAP2K1 | 0.43163787 |
| 94 | NEK2 | 0.42459942 |
| 95 | MOS | 0.42093231 |
| 96 | RPS6KL1 | 0.40233275 |
| 97 | RPS6KC1 | 0.40233275 |
| 98 | FGFR3 | 0.39547784 |
| 99 | PDK2 | 0.37761984 |
| 100 | MAPK4 | 0.36306962 |
| 101 | GRK6 | 0.35397098 |
| 102 | CHUK | 0.35332745 |
| 103 | MTOR | 0.34784207 |
| 104 | MAP2K3 | 0.33860953 |
| 105 | NLK | 0.33609645 |
| 106 | MAP3K1 | 0.33082794 |
| 107 | MAPK11 | 0.32423452 |
| 108 | MAPK7 | 0.31604159 |
| 109 | RPS6KA6 | 0.31454592 |
| 110 | CHEK2 | 0.30895988 |
| 111 | EPHB1 | 0.30205083 |
| 112 | PTK6 | 0.30103221 |
| 113 | SIK2 | 0.30057787 |
| 114 | RPS6KB1 | 0.29780376 |
| 115 | PRKCD | 0.29411939 |
| 116 | LYN | 0.27244554 |
| 117 | BTK | 0.24943525 |
| 118 | PDPK1 | 0.24909425 |
| 119 | IKBKB | 0.24124513 |
| 120 | PRKCH | 0.22051539 |
| 121 | RET | 0.21012664 |
| 122 | JAK2 | 0.20173437 |
| 123 | PRKD2 | 0.19252288 |
| 124 | MAPK3 | 0.18180287 |
| 125 | CDC42BPA | 0.16715199 |
| 126 | PRKAA1 | 0.16212757 |
| 127 | MAP3K3 | 0.14399268 |
| 128 | CSNK1A1 | 0.14101565 |
| 129 | GRK1 | 0.13574621 |
| 130 | DYRK1A | 0.13415772 |
| 131 | BRSK2 | 0.13361717 |
| 132 | MET | 0.12747462 |
| 133 | MAP3K6 | 0.12490184 |
| 134 | JAK1 | 0.12238613 |
| 135 | PDGFRA | 0.11301775 |
| 136 | RPS6KA1 | 0.10290047 |
| 137 | PRKCQ | 0.08978267 |
| 138 | MUSK | 0.08418164 |
| 139 | MAP3K10 | 0.07114639 |
| 140 | STK10 | 0.07110322 |
| 141 | PDGFRB | 0.06710360 |
| 142 | TEC | 0.06511818 |
| 143 | ABL1 | 0.06177802 |
| 144 | LRRK2 | 0.04413892 |
| 145 | MELK | 0.04107379 |
| 146 | PDK3 | 0.03408318 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protein export_Homo sapiens_hsa03060 | 8.50707832 |
| 2 | * Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 5.32907174 |
| 3 | Pancreatic secretion_Homo sapiens_hsa04972 | 4.57459929 |
| 4 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.19173972 |
| 5 | Asthma_Homo sapiens_hsa05310 | 4.13845746 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 3.74885791 |
| 7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.55408629 |
| 8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.39747695 |
| 9 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 3.27469939 |
| 10 | Fat digestion and absorption_Homo sapiens_hsa04975 | 3.14574531 |
| 11 | Folate biosynthesis_Homo sapiens_hsa00790 | 3.11796050 |
| 12 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.11312297 |
| 13 | Protein digestion and absorption_Homo sapiens_hsa04974 | 3.08765672 |
| 14 | DNA replication_Homo sapiens_hsa03030 | 2.56079700 |
| 15 | Leishmaniasis_Homo sapiens_hsa05140 | 2.40216881 |
| 16 | Other glycan degradation_Homo sapiens_hsa00511 | 2.11971288 |
| 17 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.11085199 |
| 18 | Viral myocarditis_Homo sapiens_hsa05416 | 1.96200846 |
| 19 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.95846180 |
| 20 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.72491006 |
| 21 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.72243424 |
| 22 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.66844023 |
| 23 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.63934904 |
| 24 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.63730464 |
| 25 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.59472495 |
| 26 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.59171512 |
| 27 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.57976834 |
| 28 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.57306166 |
| 29 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.50415936 |
| 30 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.49441529 |
| 31 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.41873954 |
| 32 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.36380659 |
| 33 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.25233245 |
| 34 | Tuberculosis_Homo sapiens_hsa05152 | 1.24513303 |
| 35 | Mismatch repair_Homo sapiens_hsa03430 | 1.13388630 |
| 36 | Pertussis_Homo sapiens_hsa05133 | 1.13109068 |
| 37 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.12845798 |
| 38 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.07864834 |
| 39 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.04446976 |
| 40 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.04200123 |
| 41 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.02793940 |
| 42 | Homologous recombination_Homo sapiens_hsa03440 | 0.99546103 |
| 43 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.96949040 |
| 44 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.96227821 |
| 45 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.95591128 |
| 46 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.94619148 |
| 47 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.93832097 |
| 48 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.93270799 |
| 49 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.88696074 |
| 50 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.87769181 |
| 51 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.83082733 |
| 52 | Sulfur relay system_Homo sapiens_hsa04122 | 0.82144270 |
| 53 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.81613660 |
| 54 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.81286385 |
| 55 | Measles_Homo sapiens_hsa05162 | 0.79433638 |
| 56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.77956268 |
| 57 | HTLV-I infection_Homo sapiens_hsa05166 | 0.77925541 |
| 58 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.77301713 |
| 59 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.75788587 |
| 60 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.74584011 |
| 61 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.74558293 |
| 62 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.73903089 |
| 63 | Insulin secretion_Homo sapiens_hsa04911 | 0.69528764 |
| 64 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.69060583 |
| 65 | Lysosome_Homo sapiens_hsa04142 | 0.67505981 |
| 66 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.66652849 |
| 67 | Legionellosis_Homo sapiens_hsa05134 | 0.66077201 |
| 68 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.63700290 |
| 69 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.62852066 |
| 70 | Influenza A_Homo sapiens_hsa05164 | 0.60873179 |
| 71 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.58692375 |
| 72 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.58506582 |
| 73 | Phagosome_Homo sapiens_hsa04145 | 0.58444226 |
| 74 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.57169690 |
| 75 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.56690648 |
| 76 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.53409372 |
| 77 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.53280666 |
| 78 | Apoptosis_Homo sapiens_hsa04210 | 0.52468446 |
| 79 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.52139427 |
| 80 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.49416299 |
| 81 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.48670095 |
| 82 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.48330233 |
| 83 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.46455337 |
| 84 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.46172167 |
| 85 | Prostate cancer_Homo sapiens_hsa05215 | 0.45852317 |
| 86 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.45732035 |
| 87 | Galactose metabolism_Homo sapiens_hsa00052 | 0.44699655 |
| 88 | Malaria_Homo sapiens_hsa05144 | 0.44581538 |
| 89 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.44513801 |
| 90 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.44027043 |
| 91 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.43600241 |
| 92 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.42937493 |
| 93 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.42595959 |
| 94 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.41884545 |
| 95 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.41397208 |
| 96 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40505071 |
| 97 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.40255970 |
| 98 | Histidine metabolism_Homo sapiens_hsa00340 | 0.40177448 |
| 99 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.38383930 |
| 100 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.37991373 |
| 101 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.37165677 |
| 102 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.35967324 |
| 103 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.34399269 |
| 104 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.33049935 |
| 105 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.32572184 |
| 106 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.32459812 |
| 107 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.31934970 |
| 108 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.31802059 |
| 109 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.30484444 |
| 110 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.30460446 |
| 111 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.30141806 |
| 112 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.27203589 |
| 113 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.26891333 |
| 114 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.25100662 |
| 115 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.22142423 |
| 116 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.21210142 |
| 117 | Cell cycle_Homo sapiens_hsa04110 | 0.20824183 |
| 118 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.19832893 |
| 119 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.19561303 |
| 120 | Spliceosome_Homo sapiens_hsa03040 | 0.18521966 |
| 121 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.18322472 |
| 122 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.16992017 |
| 123 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.16867827 |
| 124 | Prion diseases_Homo sapiens_hsa05020 | 0.16532875 |
| 125 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.15858041 |
| 126 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.15261177 |
| 127 | Insulin resistance_Homo sapiens_hsa04931 | 0.14129219 |
| 128 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.13475527 |
| 129 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.12870255 |
| 130 | Cocaine addiction_Homo sapiens_hsa05030 | 0.12268344 |
| 131 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.12244230 |
| 132 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.11524877 |
| 133 | Peroxisome_Homo sapiens_hsa04146 | 0.10739283 |
| 134 | Base excision repair_Homo sapiens_hsa03410 | 0.09882326 |
| 135 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.08531634 |
| 136 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.08154973 |
| 137 | Carbon metabolism_Homo sapiens_hsa01200 | 0.07679562 |
| 138 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.07612522 |
| 139 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.06079965 |
| 140 | Bladder cancer_Homo sapiens_hsa05219 | 0.05943416 |
| 141 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.05545768 |
| 142 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.05354315 |
| 143 | Hepatitis C_Homo sapiens_hsa05160 | 0.05311427 |
| 144 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.04253612 |
| 145 | Ribosome_Homo sapiens_hsa03010 | 0.03432880 |
| 146 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.03257973 |
| 147 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.01950067 |
| 148 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.01764045 |
| 149 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.00963189 |
| 150 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.00109157 |
| 151 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.00010339 |
| 152 | Pentose phosphate pathway_Homo sapiens_hsa00030 | -0.0096366 |
| 153 | Hepatitis B_Homo sapiens_hsa05161 | -0.0034765 |

